1-11 of 11
Troels K. Hansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

218-OR: The Effect of Insulin Degludec vs. Insulin Glargine U100 on Continuous Glucose Monitoring (CGM) Recorded Glycemic Metrics in People with Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia

Free
JULIE M. BRØSEN, RIKKE AGESEN, AMRA CIRIC ALIBEGOVIC, HENRIK U. ANDERSEN, PETER GUSTENHOFF, TROELS K. HANSEN, CHRISTOFFER HEDETOFT, CHARLOTTE R. STOLBERG, CLAUS B. JUHL, SUSANNE LERCHE, KIRSTEN NØRGAARD, LISE TARNOW, BIRGER THORSTEINSSON, ULRIK PEDERSEN-BJERGAARD
Journal: Diabetes
Diabetes 2022;71(Supplement_1):218-OR
https://doi.org/10.2337/db22-218-OR
Published: 01 June 2022
View articletitled, 218-OR: The Effect of Insulin Degludec vs. Insulin Glargine U100 on Continuous Glucose Monitoring (CGM) Recorded Glycemic Metrics in People with Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia
Journal Articles

SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial

Free
Katrine M. Lauritsen, Bent R.R. Nielsen, Lars P. Tolbod, Mogens Johannsen, Jakob Hansen, Troels K. Hansen, Henrik Wiggers, Niels Møller, Lars C. Gormsen, Esben Søndergaard
Journal: Diabetes
Diabetes 2021;70(3):800–808
https://doi.org/10.2337/db20-0921
Published: 17 December 2020
View articletitled, SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial
Open the PDF for SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial in another window
Meeting Abstracts

269-OR: Effect of Insulin Degludec on Frequency of Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia: The HypoDeg Trial

Free
RIKKE M. AGESEN, AMRA CIRIC ALIBEGOVIC, HENRIK U. ANDERSEN, PETER GUSTENHOFF, TROELS K. HANSEN, TONNY JENSEN, SR., CLAUS B. JUHL, ANDREAS K. JENSEN, SUSANNE LERCHE, KIRSTEN NØRGAARD, HANS-HENRIK D. PARVING, ANNE L. SØRENSEN, LISE TARNOW, BIRGER THORSTEINSSON, ULRIK PEDERSEN-BJERGAARD
Journal: Diabetes
Diabetes 2020;69(Supplement_1):269-OR
https://doi.org/10.2337/db20-269-OR
Published: 01 June 2020
View articletitled, 269-OR: Effect of Insulin Degludec on Frequency of Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia: The HypoDeg Trial
Meeting Abstracts

270-OR: Nocturnal Hypoglycemia with Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Severe Nocturnal Hypoglycemia (HypoDeg): A CGM Substudy

Free
JULIE M. BRØSEN, RIKKE M. AGESEN, AMRA CIRIC ALIBEGOVIC, HENRIK U. ANDERSEN, PETER GUSTENHOFF, TROELS K. HANSEN, TONNY JENSEN, SR., CLAUS B. JUHL, SUSANNE LERCHE, KIRSTEN NØRGAARD, HANS-HENRIK D. PARVING, LISE TARNOW, BIRGER THORSTEINSSON, ULRIK PEDERSEN-BJERGAARD
Journal: Diabetes
Diabetes 2020;69(Supplement_1):270-OR
https://doi.org/10.2337/db20-270-OR
Published: 01 June 2020
View articletitled, 270-OR: Nocturnal Hypoglycemia with Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Severe Nocturnal Hypoglycemia (HypoDeg): A CGM Substudy
Meeting Abstracts

278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

Free
MATTHIAS G. VON HERRATH, STEPHEN C. BAIN, BRUCE W. BODE, JESPER OLE CLAUSEN, KEN COPPIETERS, LEYLYA GAYSINA, JANUSZ GUMPRECHT, TROELS K. HANSEN, CHANTAL MATHIEU, CRISTOBAL MORALES PORTILLO, OFRI MOSENZON, STINE SEGEL, GEORGE M. TSOUKAS, THOMAS PIEBER
Journal: Diabetes
Diabetes 2020;69(Supplement_1):278-OR
https://doi.org/10.2337/db20-278-OR
Published: 01 June 2020
View articletitled, 278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes
Meeting Abstracts

40-LB: Association between Complement and Severe Retinal Complications in Type 1 Diabetes—An 18-Year Follow-Up Study

Free
CHARLOTTE B. HOLT, INGEBORG TORP HOFFMANN-PETERSEN, JAKOB A. øSTERGAARD, HANS- HENRIK D. PARVING, SR., STEFFEN THIEL, PETER HOVIND, LISE TARNOW, PETER ROSSING, TROELS K. HANSEN
Journal: Diabetes
Diabetes 2019;68(Supplement_1):40-LB
https://doi.org/10.2337/db19-40-LB
Published: 01 June 2019
View articletitled, 40-LB: Association between Complement and Severe Retinal Complications in Type 1 Diabetes—An 18-Year Follow-Up Study
Meeting Abstracts

375-P: Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study

Free
HAROLD W. DE VALK, MICHAEL FEHER, TROELS K. HANSEN, JOHAN H. JENDLE, ÁNGEL MERCHANTE, METTE M. KOEFOED, EHSAN PARVARESH RIZI, ESTHER ZIMMERMANN, GIAN PAOLO FADINI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):375-P
https://doi.org/10.2337/db19-375-P
Published: 01 June 2019
View articletitled, 375-P: Switching to Insulin Degludec from Other Basal Insulins Reduces Rates of Hypoglycemia across Patient Subgroups in Routine Clinical Care: The ReFLeCT Study
Meeting Abstracts

374-P: Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study

Free
HAROLD W., DE VALK, MICHAEL FEHER, TROELS K. HANSEN, JOHAN H. JENDLE, ÁNGEL MERCHANTE, METTE M. KOEFOED, EHSAN PARVARESH RIZI, ESTHER ZIMMERMANN, GIAN PAOLO FADINI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):374-P
https://doi.org/10.2337/db19-374-P
Published: 01 June 2019
View articletitled, 374-P: Reduced Rates of Hypoglycemia Irrespective of the Definition Used When Switching to Insulin Degludec (degludec) from Other Basal Insulins in Routine Clinical Care: The ReFLeCT Study
Meeting Abstracts

The Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 Diabetes

Free
GRY H. DØRFLINGER, JAKOB A. ØSTERGAARD, SANNE FISKER, SOREN T. KNUDSEN, TROELS K. HANSEN
Journal: Diabetes
Diabetes 2018;67(Supplement_1):942-P
https://doi.org/10.2337/db18-942-P
Published: 01 July 2018
View articletitled, The Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 Diabetes
Journal Articles

Elevated MBL Concentrations Are Not an Indication of Association Between the MBL2 Gene and Type 1 Diabetes or Diabetic Nephropathy

Open Access
Mari A. Kaunisto, Lisa Sjölind, Riitta Sallinen, Kim Pettersson-Fernholm, Markku Saraheimo, Sara Fröjdö, Carol Forsblom, Johan Fagerudd, Troels K. Hansen, Allan Flyvbjerg, Maija Wessman, Per-Henrik Groop, for the FinnDiane Study Group
Journal: Diabetes
Diabetes 2009;58(7):1710–1714
https://doi.org/10.2337/db08-1495
Published: 14 April 2009
View articletitled, Elevated MBL Concentrations Are Not an Indication of Association Between the MBL2 Gene and Type 1 Diabetes or Diabetic Nephropathy
Open the PDF for Elevated MBL Concentrations Are Not an Indication of Association Between the MBL2 Gene and Type 1 Diabetes or Diabetic Nephropathy in another window
Includes: Supplementary data
Journal Articles

Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes

Free
Troels K. Hansen, Lise Tarnow, Steffen Thiel, Rudi Steffensen, Coen D. Stehouwer, Casper G. Schalkwijk, Hans-Henrik Parving, Allan Flyvbjerg
Journal: Diabetes
Diabetes 2004;53(6):1570–1576
https://doi.org/10.2337/diabetes.53.6.1570
Published: 01 June 2004
View articletitled, Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes
Open the PDF for Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes in another window